Immunocytokines: a review of molecules in clinical development for cancer therapy by List T, Neri D

Get full text

Chemical site-selective protein modification: Development of a traceless vascular targeting ADC for cancer therapy by Bernardes, G, Neri, D, Davis, B

Targeted IL‐4 therapy synergizes with dexamethasone to induce a state of tolerance by promoting Treg cells and macrophages in mice with arthritis by Kawalkowska, J, Hemmerle, T, Pretto, F, Matasci, M, Neri, D, Williams, R

Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications by Favalli, N, Bassi, G, Pellegrino, C, Millul, J, De Luca, R, Cazzamalli, S, Yang, S, Trenner, A, Mozaffari, NL, Myburgh, R, Moroglu, M, Conway, SJ, Sartori, AA, Manz, MG, Lerner, RA, Vogt, PK, Scheuermann, J, Neri, D